Through several CHPA member company donations, 144 U.S. schools of pharmacy received over 100 different OTC medicines, medical devices, and dietary supplements to educate and prepare future pharmacists.
We strongly urge the CIC not to “list” acetaminophen as a carcinogen due to the lack of evidence that it has been “clearly shown” to cause cancer, and due to the unnecessary confusion and fear it could cause among consumers and patients.
This information is submitted on behalf of CHPA in response to the September 20, 2019 OEHHA notice: Announcement of the Carcinogen Identification Committee Meeting Scheduled for December 5, 2019, Notice of Availability of Hazard Identification Materials for Acetaminophen and Notice of Public Comment Period.
The Senate HELP Committee made a strong bipartisan move to modernize the regulatory system overseeing most OTC medicines by approving S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act by voice vote.
CHPA issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, sponsored by Senators Johnny Isakson (R-Ga.) and Bob Casey (D-Pa.).
The Consumer Healthcare Products Association (CHPA) issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act.
Today, the House Ways and Means Committee took an important step toward reinstating consumers’ ability to purchase OTC medicines with tax-preferred savings accounts, including FSAs and HSAs.
On behalf of the Health Choices Coalition, we write to applaud efforts to restore OTC medications to full tax-preferred status, eliminating the need to first obtain a prescription.
It only took a moment for Sugey and Carlos’s toddler to accidentally swallow medicine that was left within his reach. It can happen to anyone. Take 90 seconds to watch their story, and learn how to keep your family safe.
